A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM

NCT02886065 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Smoldering Multiple Myeloma

Interventions

DRUG: Hiltonol
DRUG: Citarinostat
DRUG: Lenalidomide
BIOLOGICAL: PVX-410

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]